semaglutide fda update Updates Ozempic Label amid Reports of Intestinal Blockages Following FDA nod, Novo Nordisk

Nature 365: 441445

Bacteriostatic water has also landed on the FDA drug shortage list more than once over the years

Studies have shown that people with high levels of estrogen have a higher risk of increased weight gain, bloating, water retention, and other complications.* DIM, short for diindolylmethane, is a hormone balancer

Semaglutide also has warnings for pancreatitis, diabetic retinopathy complications, hypoglycemia that can be severe, acute kidney injury, acute gallbladder disease, hypersensitivity reactions, and pulmonary aspiration during general anesthesia or deep sedation

These studies may investigate retatrutides effects on other metabolic health factors, including cholesterol or heart risk

In addition, GLP-1R overexpression results in improved cognitive function in mice and GLP-1R knockout severely impairs cognitive ability (5, 117, 118)